Immunogenicity of COVID-19 vaccines in patients with haematological malignancy: A systematic review and meta-analysis
Joanne S.K. Teh, Julien Coussement, Zoe C. F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A. Slavin, View ORCID ProfileBenjamin W. Teh
doi: https://doi.org/10.1101/2021.11.06.21265967
Joanne S.K. Teh
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Julien Coussement
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Zoe C. F. Neoh
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Tim Spelman
3Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Smaro Lazarakis
4Health Sciences Library, Royal Melbourne Hospital, Parkville, Victoria, Australia
Monica A. Slavin
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
6Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Benjamin W. Teh
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 08, 2021.
Immunogenicity of COVID-19 vaccines in patients with haematological malignancy: A systematic review and meta-analysis
Joanne S.K. Teh, Julien Coussement, Zoe C. F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A. Slavin, Benjamin W. Teh
medRxiv 2021.11.06.21265967; doi: https://doi.org/10.1101/2021.11.06.21265967
Immunogenicity of COVID-19 vaccines in patients with haematological malignancy: A systematic review and meta-analysis
Joanne S.K. Teh, Julien Coussement, Zoe C. F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A. Slavin, Benjamin W. Teh
medRxiv 2021.11.06.21265967; doi: https://doi.org/10.1101/2021.11.06.21265967
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (688)
- Anesthesia (184)
- Cardiovascular Medicine (2733)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12380)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4243)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2743)
- Health Policy (1015)
- Hematology (369)
- HIV/AIDS (875)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4024)
- Nursing (216)
- Nutrition (598)
- Oncology (2117)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (476)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6639)
- Radiology and Imaging (1443)
- Respiratory Medicine (885)
- Rheumatology (420)
- Sports Medicine (350)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)